Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionTetravalent HIV vaccine containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsPrevent HIV-1 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today